This site uses cookies to store information on your computer. I'm fine with this Cookie information
Follow is on Twitter Like us on Facebook Follow us on Instagram

*UPDATED* Hospital visiting changes, home testing kits, Vaccine info, general info and guidance for public, NHSGGC staff, and community-based services.



For symptom control, all patients should be offered a β-blocker, unless contra-indicated (e.g. asthma, bradycardia <50bpm).

COPD is not a contra-indication.

β-blockers have also been shown to reduce mortality if started soon after a coronary event (as well as helping angina control and blood pressure management if required).

If not already on a β-blocker and less than 5 years since MI/ACS, then start a β-blocker.

Click here for further information. The BNF also has useful information

For mortality benefit and symptom control, Atenolol 25 mg bd is the recommended drug and starting dose (except in heart failure patients - click here for LVSD guideline).

Last Updated: 04 October 2021